Close Menu

NEW YORK, June 15 (GenomeWeb News) - Accelr8 Technology today reported dwindling revenues and increased losses for the third quarter of its fiscal year 2004, which ended April 30.

 

The company had $132,000 in revenues for the quarter, down from $276,000 during the same quarter last year.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.